Advertisement

Topics

Search Results for "Ranbaxy Launches Atorvastatin In Us"

21:01 EDT 4th May 2016 | BioPortfolio

Matching Channels

None

Matching News

Sun's so-long wave to Tipperary: Indian firm to close Ranbaxy plant this year

Sun Pharmaceuticals has confirmed it will close a Ranbaxy Laboratories facility in Ireland by the end of the year.

Sun selling Ohio plant in post-Ranbaxy network restructure

Sun Pharma has announced it will divest a plant in Ohio to further consolidate manufacturing operations following its $4bn acquisition of Ranbaxy.

Sun Pharma Launches First OTC Drug

India’s Sun Pharmaceutical recently rolled out its first OTC drug, antacid Pepmelt, as it leverages the consumer healthcare portfolio acquired in its Ranbaxy Laboratories buy.

Sun Sells US Plant As It Tackles Post-Ranbaxy Consolidation

India's Sun Pharma has clinched a deal to sell a US plant as part of a consolidation drive in the wake of its purchase of rival Ranbaxy, amid improving investor sentiment toward the country's biggest ...

Sun Profit Dives On Ranbaxy Merger Costs

Sun Pharmaceutical Industries, India’s biggest drug maker by sales, has reported a 30% drop in quarterly net profit from a year earlier, undershooting analysts’ expectations for a third straight t...

Ranbaxy Whistle Blower Is Back; Takes Indian Regulator To Court

Ranbaxy whistle blower Dinesh Thakur has fired a fresh salvo - this time taking the Indian drugs regulator to court for alleged lax enforcement of rules concerning the safety of medicines in the count...

Ranbaxy Whistle-Blower Is back; Takes Indian Regulator To Court

Ranbaxy whistle-blower Dinesh Thakur has fired a fresh salvo - this time taking the Indian drugs regulator to court for alleged lax enforcement of rules concerning the safety of medicines in the count...

High-dose atorvastatin fails to reduce risk for kidney injury after cardiac surgery

Compared with placebo, high-dose atorvastatin did not decrease risk for acute kidney injury after cardiac surgery, according to findings presented at the Critical Care Congress and published in JAMA. ...

Matching PubMed Articles

Quercetin does not alter the oral bioavailability of Atorvastatin in rats.

The study was undertaken to evaluate the effect of Quercetin on the pharmacokinetics of Atorvastatin Calcium. In-vivo Pharmacokinetic studies were performed on rats in a single dose study and multiple...

Binding interaction of atorvastatin with bovine serum albumin: Spectroscopic methods and molecular docking.

The interaction of atorvastatin with bovine serum albumin (BSA) was investigated using multi-spectroscopic methods and molecular docking technique for providing important insight into further elucidat...

Atorvastatin Use Associated With Acute Pancreatitis: A Case-Control Study in Taiwan.

Few data are present in the literature on the relationship between atorvastatin use and acute pancreatitis. The aim of this study was to explore this issue in Taiwan.Using representative claims data e...

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.

The use of atorvastatin is rapidly increasing among statins since the introduction of generics. However, only limited data are available on its current use and the effectiveness outside of randomised ...

Physiologically Based Pharmacokinetic Modeling of Disposition and Drug-Drug Interactions for Atorvastatin and its Metabolites.

Atorvastatin is the most commonly used of all statins to lower cholesterol. Atorvastatin is extensively metabolized in both gut and liver to produce several active metabolites. The purpose of the pres...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement